Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
26 participants
OBSERVATIONAL
2013-05-31
2016-09-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In addition long-term clinical follow-ups are planned for all patients treated with Absorb in the institution
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients.
NCT01759290
Independent OCT Registry on Very Late Bioresorbable Scaffold Thrombosis
NCT03180931
Optical Coherence Tomography to Improve Outcome for Coronary Revascularisation Using Bioresorbable Vascular Scaffolds
NCT02683356
Coronary Artery Healing and Bioresorbable Scaffold
NCT03016624
Optimization of Complex Percutaneous Coronary Intervention With Liberal Use of Intracoronary Imaging Versus Contemporary Practice
NCT07114393
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Absorb-BVS
Bioresorbable vascular scaffold implantation
Absorb-BVS
BVS patients undergoing optical coherence tomography examination at follow-up
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Absorb-BVS
BVS patients undergoing optical coherence tomography examination at follow-up
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
OTHER
LMU Klinikum
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Julinda Mehilli
Director, Interventional cardiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julinda Mehilli, MD
Role: STUDY_CHAIR
Munich University Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Munich University Clinic
Munich, Bavarian, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Baquet M, Brenner C, Wenzler M, Eickhoff M, David J, Brunner S, Theiss H, Massberg S, Guagliumi G, Mehilli J. Impact of Clinical Presentation on Early Vascular Healing After Bioresorbable Vascular Scaffold Implantation. J Interv Cardiol. 2017 Feb;30(1):16-23. doi: 10.1111/joic.12359. Epub 2016 Nov 28.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MucC002-14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.